Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS-CoV-2. Cui Y, Hu C, Cheng Y, Han X, et al. Int J Dermatol 2022;61:252-256.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cui Y, Hu C, Cheng Y, Han X, et al. Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS-CoV-2. Int J Dermatol 2022;61:252-256.
PMID: 34520570